Gary K. Zammit

Gary K. Zammit

Company: Clinilabs Drug Development Corporation

Job title: President & CEO


Gary Zammit, PhD, is the President & CEO of Clinilabs, a full-service CRO that provides clinical drug development to industry, focusing on CNS therapeutics.  He also is an Associate Clinical Professor of Psychiatry, Icahn School of Medicine at Mount Sinai (New York, NY).  Dr. Zammit earned a Ph.D. degree in clinical psychology from the University of Toledo (Toledo, OH), where he won both the Turin Service Award and the Leckie Scholar Award.  He completed an internship and clinical research fellowship in the Department of Psychiatry at the New York Hospital – Cornell University Medical College (White Plains, NY), where he won the Alumni Award for Excellence.  Dr. Zammit is widely sought for his expertise in neuropsychiatric drug development, particularly in the field of sleep medicine.  He has authored two books and over 230  articles and abstracts that have appeared in medical journals.


Live Q&A 10:30 am

Read more

day: Day One

The Role of the CRO in Patient-Centric CNS Clinical Trials 10:05 am

• Gain insight into the role of the CRO in the engagement and retention of subjects with neuropsychiatric disorders • Appreciate the value of the CRO in the deployment and use of technology in patient-centric CNS trials • Learn how CROs manage the patient-centric CNS trial process from selection of endpoints to study execution and…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.